Cytokine analysis of myeloma and normal donors
| . | Bone marrow . | Peripheral blood . | ||
|---|---|---|---|---|
| Myeloma (N = 40) . | Normal (N = 12) . | Myeloma (N = 40) . | Normal (N = 12) . | |
| IL-6, pg/mL | 29.6 (2.0-70.2) | 3.7 (0-20.0) | 6.5 (4.4-8.0) | 2.3 (2.0-2.4) |
| TGF-β, pg/mL | 59.9 (20.8-80.0) | 52.6 (39.3-79.9) | 17.5 (1.7-39.4) | 16.1 (2.4-35.5) |
| IL-23, pg/mL | 246.4 (20.0-650.0) | 35.9 (28.0-44.0) | 19.6 (0-30.0) | 18 (11.0-24.0) |
| IL-1β, pg/mL | 29.9 (10.1-69.2) | 5.8 (0-9.2) | 4.5 (2.4-6.2) | 3.5 (0-4.9) |
| IL-17, pg/mL | 12.2 (2.2-35.0) | 5.1 (3.8-8.8) | 0.4 (0-2.2) | 0 (0-0) |
| MIP-1α, pg/mL | 1059.5 (98.2-4860.0) | 42.6 (38.4-62.8) | 14.8 (0-56.2) | 0 (0-0) |
| . | Bone marrow . | Peripheral blood . | ||
|---|---|---|---|---|
| Myeloma (N = 40) . | Normal (N = 12) . | Myeloma (N = 40) . | Normal (N = 12) . | |
| IL-6, pg/mL | 29.6 (2.0-70.2) | 3.7 (0-20.0) | 6.5 (4.4-8.0) | 2.3 (2.0-2.4) |
| TGF-β, pg/mL | 59.9 (20.8-80.0) | 52.6 (39.3-79.9) | 17.5 (1.7-39.4) | 16.1 (2.4-35.5) |
| IL-23, pg/mL | 246.4 (20.0-650.0) | 35.9 (28.0-44.0) | 19.6 (0-30.0) | 18 (11.0-24.0) |
| IL-1β, pg/mL | 29.9 (10.1-69.2) | 5.8 (0-9.2) | 4.5 (2.4-6.2) | 3.5 (0-4.9) |
| IL-17, pg/mL | 12.2 (2.2-35.0) | 5.1 (3.8-8.8) | 0.4 (0-2.2) | 0 (0-0) |
| MIP-1α, pg/mL | 1059.5 (98.2-4860.0) | 42.6 (38.4-62.8) | 14.8 (0-56.2) | 0 (0-0) |